COVID-19

Now, more than ever, is the time that nurses, pharmacists, pharmacy technicians, and physicians can help those who need access to life-saving medicines, and Dispensary of Hope is a resource.

Pharmacy Times will continue to bring readers the latest information on COVID-19 developments, in a variety of formats.

An expert panel discussion for clinicians on the most important factors surrounding a safe return-to-school plan, including testing, masking, social distancing, vaccine prioritization and more.

Unique model demonstrates how clinical pharmacy services could be integrated into an interprofessional telehealth clinic.

Researchers attempt to address a lack of evidence showing that schools have a role in the transmission of COVID-19.

Top news of the week from Pharmacy Times®.

Leaders of Operation Warp Speed optimistic for a coronavirus disease 2019 vaccine following multi-billion dollar investments in several candidates.

The 2020 NCPA Annual Convention will be held exclusively online October 18-19, 2020.

Uncertainties persist regarding the transmission of COVID-19 among students in educational settings as schools prepare to reopen in some form.

The death rate for patients who experienced a normally lower-risk heart attack rose sharply during the peak of the coronavirus disease 2019 pandemic.

Frontline health care workers have a 3-fold increased risk of contracting coronavirus disease 2019 despite use of personal protective equipment.

Moderna will manufacture doses of its experimental coronavirus disease 2019 vaccine candidate as clinical trials are ongoing to expedite the production process.

Intranasal vaccine platform may allow for an immune response to be induced more precisely to provide the best possible protection from coronavirus disease 2019.

Pharmacy Times® interviewed Clayton Edwards, RPh, MBA, chief operating officer of AllianceRx Walgreens Prime, on the importance of disaster preparation in pharmacies during hurricane season in the midst of a pandemic.

As public trust in vaccines has fallen, it’s up to pharmacists to combat misinformation.

Pharmacists should be vocal in objecting to unproven therapies for COVID-19 being widely used primarily based on wishful thinking.

As patients return to their routines of returning to pharmacies and the inevitable discussions about COVID-19 begin, it may be a good time to discuss the range of tests that the CDC recommends.

National Association of Chain Drug Stores joins with 20 other groups in asking Congress to take action that includes designating pharmacists as providers under Medicare.

New research indicates a need to understand the mental health impacts of the coronavirus disease 2019 pandemic.

Helath care workers report higher levels of stress, anxiety, and fatigue, as well as reduced feelings of control over their lives, as a result of COVID-19.

Cancer care providers have increasingly been using biosimilars on a case-by-case basis with patients.

Gilead Sciences is increasing the global supply of the investigational drug remdesivir in preparation for demand in fighting COVID-19.

Top news of the week from Pharmacy Times®.

New testing method may improve the speed, handling time, and cost of laboratory tests for coronavirus disease 2019.

In a world increasingly influenced by technology, there is ample opportunity to leverage automation within pharmacies that can not only improve operations, but support patient wellness.